Kidney transplantation
Conditions
Interventions
Calcineurin inhibitor + basiliximab + steroid + mizoribine
Sponsors
Study group on a multi-drug combination therapy for renal transplantation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Kidney transplantation. 2.Gender free, any case of uremia. 3. Aged 16 years to 70 years. 4.ABO blood type compatible (including semi-compatible). The patient or whose family has submitted (if the patient is showing disturbance of consciousness or decreased ability to understand) written consent forms based on their free choice once adequate information and understandings are obtained regarding the study upon the participation.
Exclusion criteria
Exclusion criteria: 1. The patient who has a history of hypersensitivity against components of either one of this study drugs. 2. The patient who has leucopenia. 3. The patient who is pregnant or a female patient who is expecting to become pregnant. 4. The patients who showed a positive result with cross match test. 5. The patient who recived ABO incompatible donor. 6. The patient with whom the physician-in-charge considered inappropriate as a subject of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rejection (incidence, types, severity) CMV and BKV infection | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient survival, graft survival, incidence of adverse effects / abnormalities in the laboratory values. | — |
Countries
Japan
Outcome results
None listed